Abstract
Nearly 15 million cosmetic procedures are performed annually in the U.S., including breast augmentations, lifts, and reductions. One of the more common challenges following these surgeries involves wound complications such as scarring or postoperative breakdown at incision sites. These outcomes may lead to additional interventions and increased care costs.
Case Overview
After significant weight loss, the patient in this review underwent a lower body lift combined with breast reduction surgery and a nipple–areolar transplant. Postoperatively, she developed wound dehiscence at the donor site. Following eight weeks of standard care without meaningful progress, she was referred for further evaluation.
At presentation, the wound measured 3.5 cm × 3.5 cm × 1.25 cm deep with no visible epithelialization. The patient then received a single application of Wharton’s Jelly (WJ) flowable perinatal tissue allograft (CryoText™) alongside twelve hyperbaric oxygen therapy (HBOT) sessions over a seven-week period.
Results
At the conclusion of observation, the wound demonstrated complete closure with full epithelialization. No additional surgical intervention was required during the review period.
Conclusion
This single-patient case highlights the potential role of Wharton’s Jelly flowable allografts as a supplementary option in managing complex postoperative cosmetic wounds. Future studies are warranted to further evaluate procedural protocols, application considerations, and broader clinical use cases.